Back
Cabaletta Bio Vs. ACADIA Pharmaceuticals Industry Stock Comparison
Sell
17
CABA
Cabaletta Bio
Last Price:
10.17
Seasonality Move:
30.53%
Sell
21
ACAD
ACADIA Pharmaceuticals
Last Price:
15.09
Seasonality Move:
6.93%
Sell
17
Cabaletta Bio (CABA)
is a Sell
Is Cabaletta Bio a Buy, Sell or Hold?
- The current Cabaletta Bio [CABA] share price is $10.17. The Score for CABA is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
- CABA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
21
ACADIA Pharmaceuticals (ACAD)
is a Sell
Is ACADIA Pharmaceuticals a Buy, Sell or Hold?
- The current ACADIA Pharmaceuticals [ACAD] share price is $15.08. The Score for ACAD is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
- ACAD is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CABA Stock Price Chart
What is Cabaletta Bio's stock price today?
-
The Cabaletta Bio share price today is $10.17
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CABA is experiencing buying pressure, which is a positive indicator for future bullish movement.
ACAD Stock Price Chart
What is ACADIA Pharmaceuticals's stock price today?
-
The ACADIA Pharmaceuticals share price today is $15.08
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ACAD is experiencing slight selling pressure.
CABA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1 | Sell |
| Relative Strength Index (14 RSI): | 33.02 | Sell |
| Chaikin Money Flow: | 545031 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.68 - 12.58) | Sell |
| Bollinger Bands (100): | (13.27 - 22.47) | Sell |
ACAD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.58 | Sell |
| Relative Strength Index (14 RSI): | 39.73 | Sell |
| Chaikin Money Flow: | -200871 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (14.86 - 16.74) | Sell |
| Bollinger Bands (100): | (16.11 - 25.61) | Sell |
CABA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 10.87 | Sell |
| 20-day SMA: | 11.68 | Sell |
| 50-day SMA: | 13.86 | Sell |
| 200-day SMA: | 17.14 | Sell |
| 8-day EMA: | 10.74 | Sell |
| 20-day EMA: | 11.62 | Sell |
| 50-day EMA: | 13.78 | Sell |
| 200-day EMA: | 15.79 | Sell |
ACAD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 15.2 | Sell |
| 20-day SMA: | 15.52 | Sell |
| 50-day SMA: | 16.69 | Sell |
| 200-day SMA: | 22.91 | Sell |
| 8-day EMA: | 15.11 | Sell |
| 20-day EMA: | 15.54 | Sell |
| 50-day EMA: | 17.14 | Sell |
| 200-day EMA: | 21.25 | Sell |
Cabaletta Bio Earnings Growth & CABA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.04 per share, a decrease this year of $0.58 per share, and an increase next year of $0.04 per share.
ACADIA Pharmaceuticals Earnings Growth & ACAD Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.59 per share, an increase next quarter of $0.06 per share, an increase this year of $0.90 per share, and an increase next year of $0.54 per share.
Cabaletta Bio Technical Analysis
| May 17 | May 20 | May 21 | May 22 | May 23 | May 24 | May 28 | May 29 | May 30 | May 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 17 | 20 | 21 | 22 | 23 | 24 | 28 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
ACADIA Pharmaceuticals Technical Analysis
| May 17 | May 20 | May 21 | May 22 | May 23 | May 24 | May 28 | May 29 | May 30 | May 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 17 | 20 | 21 | 22 | 23 | 24 | 28 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||